Why is Surgery Partners stock surging today?
Surgery Partners (SGRY) stock rose 10% in pre-market trading after Q3 2026 earnings beat expectations, with revenue of $829M and EPS of $0.11. The company is being acquired by HealthSpan Partners for $23.50 per share, a 49% premium. Shares traded at $25.50, above the merger price and 52-week high of $23.37. The broader market and healthcare sector also gained.
How this was made
The 30-second read
Why it matters
The earnings beat and merger premium together sparked a near‑10% pre‑market jump, indicating strong short‑term buying interest.
Market read
The news provides a clear, actionable catalyst for traders in the healthcare services sector.
What to watch
Potential integration risks and Bain Capital's equity rollover may temper upside.
Background
Surgery Partners announced an all‑cash $5.7 B acquisition by HealthSpan Partners and released Q3 results ahead of schedule.
Ticker impact
Q3 2026 earnings beat expectations and merger premium drove a ~10% pre‑market surge.
upward pressure as investors price in earnings beat and merger premium.
The surprise earnings beat and premium‑deal dynamics are fresh, material, and moved the stock 10% pre‑market.
Market effects
Healthcare services sector may see broader buying as a high‑profile merger proceeds.
U.S. equity markets gain from risk‑on sentiment.
Limited to U.S. healthcare and M&A investors.
Counterpoint
If the merger faces regulatory hurdles, the rally could reverse.
Key entities
- companySurgery Partners
Operator of ambulatory surgery centers, ticker SGRY.
- companyHealthSpan Partners
Affiliate of Bon Secours Mercy Health, acquirer.

